These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 564572)

  • 21. Comparative analysis between the reserve albumin-binding capacity (HBABA method) and the saturation index of hyperbilirubinemic sera.
    Priolisi A; Ziino L
    Biol Neonate; 1971; 19(4):258-71. PubMed ID: 5169961
    [No Abstract]   [Full Text] [Related]  

  • 22. [Reserve binding capacity of serum albumin for bilirubin in severe jaundice of the newborn infant].
    Rossipal E; Teubl I; Rosegger H
    Padiatr Padol; 1971 Jun; 6(2):205-12. PubMed ID: 5005469
    [No Abstract]   [Full Text] [Related]  

  • 23. [Importance of the determination of bilirubin not bound to albumin on a sephadex gel column in neonatal jaundice].
    Rusu O; Popa M; Nanu R; Taulescu G
    Pediatria (Bucur); 1973; 22(1):75-82. PubMed ID: 4798769
    [No Abstract]   [Full Text] [Related]  

  • 24. [Importance of the determination of bilirubin not bound to albumin on a sephadex gel column in neonatal jaundice].
    Rusu O; Popa M; Nanu R; Taulescu G
    Pediatria (Bucur); 1973; 22(1):75-82. PubMed ID: 4739035
    [No Abstract]   [Full Text] [Related]  

  • 25. [Diagnostic significance of the determination of bilirubin fractions in the hemolytic disease of newborns].
    Hodr R; Strnad L
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1967; 10(1):21-7. PubMed ID: 5239111
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of serologic methods used in the diagnosis of hemolytic disease of newborns.
    Kuśnierz G
    Arch Immunol Ther Exp (Warsz); 1971; 19(5):627-33. PubMed ID: 4952642
    [No Abstract]   [Full Text] [Related]  

  • 27. Antenatal serologic assessment of severity of hemolytic disease due to anti-Rh.
    Frankowska K
    Arch Immunol Ther Exp (Warsz); 1971; 19(5):613-9. PubMed ID: 5006484
    [No Abstract]   [Full Text] [Related]  

  • 28. [Diagnosis of hemolytic disease of the newborn on the basis of an hr' (c)-conflict].
    Dobronravov AV; Zinger TI
    Probl Gematol Pereliv Krovi; 1976 Jan; 21(1):55. PubMed ID: 1273066
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hemolytic disease of the newborn due to incompatibility of the ABO system. Bilirubin encephalopathy].
    Malaguzzi Valeri O; Sbraccia C; Carapella De Luca E; Di Piero G; Mencarini L; Natoli G; Natoli V; Valeri OM
    Minerva Pediatr; 1967 Sep; 19(36):1678-86. PubMed ID: 5629556
    [No Abstract]   [Full Text] [Related]  

  • 30. Estimation of the albumin binding capacity in Rh immunization. Practical and theoretical interest. Personal experience.
    Streiff F; Vigneron C; Pierson M; Olive D; Genetet B; Pierron N
    Ann Ostet Ginecol Med Perinat; 1971 Sep; 92(9):613-4. PubMed ID: 5003296
    [No Abstract]   [Full Text] [Related]  

  • 31. [Spectrophotometric study and chloroform extraction for the determination of bilirubin and associated pigments in the amniotic fluid].
    Sendrail A; Biermé S; Cabannes R; de Boissezon JF
    Rev Fr Transfus; 1969; 12(1):Suppl:305-15. PubMed ID: 4987781
    [No Abstract]   [Full Text] [Related]  

  • 32. [Evaluation of potential neuro-toxic effect of circulating bilirubin during neonatal period: I. Analytical comparison between residual binding capacity of albumin (R.B.C.A.) and saturation index (S.I.)].
    Priolisi A; Zino L
    Pediatria (Napoli); 1970 Dec; 78(6):983-1007. PubMed ID: 5535194
    [No Abstract]   [Full Text] [Related]  

  • 33. "ABO hemolytic disease".
    Smith DW; Stevenson DK
    Clin Pediatr (Phila); 1986 Feb; 25(2):116. PubMed ID: 3943260
    [No Abstract]   [Full Text] [Related]  

  • 34. [New prognostic evaluation of fetal hemolytic disease].
    Mares J
    Cesk Gynekol; 1967 Aug; 32(6):477-80. PubMed ID: 4967171
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hemolytic disease of the newborn due to immunologic (ABO incompatibility excluded) and non-immunologic causes].
    Gerbasi M; Cutillo S; Albeggiani A; Balsamo V; La Grutta A; Mollica F; Priolisi A
    Minerva Pediatr; 1967 Sep; 19(36):1670-7. PubMed ID: 5629555
    [No Abstract]   [Full Text] [Related]  

  • 36. [The importance of pregnancy consultation in prophylaxis of hemolytic disease of the newborn].
    Kölbl H
    Wien Med Wochenschr; 1966 Nov; 116(46):981-3. PubMed ID: 4965843
    [No Abstract]   [Full Text] [Related]  

  • 37. [Icterometric studies in newborn infants with hemolytic disease].
    Hodr R; Holcová M; Plachý V
    Cesk Pediatr; 1965 Oct; 20(10):855-9. PubMed ID: 5892327
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical follow-up studies on late prognosis of Rh-related hemolytic diseases of the newborn. VI. Factor analysis for the catamnestic evaluation of Rh-related hemolytic disease of the newborn].
    Klemm PG
    Padiatr Grenzgeb; 1970; 9(3):202-7. PubMed ID: 5534910
    [No Abstract]   [Full Text] [Related]  

  • 39. [A simple interpretation of spectrophotometric curves of amniotic fluid in hemolytic disease of the newborn].
    Baumgarten K; Fröhlich H
    Bibl Haematol; 1969; 32():83-7. PubMed ID: 4980807
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of phototherapy in ABO hemolytic disease of the newborn.
    Bajpai PC; Misra PK; Das VK; Tripathi TK; Kapoor CL
    Indian J Med Res; 1973 Nov; 61(11):1658-65. PubMed ID: 4799677
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.